Updated October 8, 2026
Subscribe
NewsNovo
REGULATORYNexGel Sets 1-for-20 Reverse Stock Split Effective October 12ENERGYStocks Rise as Oil Falls and Bond Yields RetreatMACROBank of England warns rates likely to rise if Middle East war persistsREGULATORYComedians criticize SiriusXM for cutting working-class artists from Maniscalco channelWORLDExperts compare AI alarm to Y2K, warning regulation may stall innovationENERGYMeta Quest 3S drops to $297.49 during Amazon October Prime DayREGULATORYNexGel Sets 1-for-20 Reverse Stock Split Effective October 12ENERGYStocks Rise as Oil Falls and Bond Yields RetreatMACROBank of England warns rates likely to rise if Middle East war persistsREGULATORYComedians criticize SiriusXM for cutting working-class artists from Maniscalco channelWORLDExperts compare AI alarm to Y2K, warning regulation may stall innovationENERGYMeta Quest 3S drops to $297.49 during Amazon October Prime Day
Coverage

Health

4 stories on the Health beat — filed by the NewsNovo desk.

All newsMarkets515Crypto426Macro306Regulatory201Deals194Earnings161World68Energy67News54Tech4Health4Product1

Health

Sorted by most recent
01
Health

AIDS activists say Biden administration settled for too little in Gilead HIV patent deal

After more than a year of pressure, a group of AIDS activists gained access to the R&D agreement central to a settlement between the U.S. government and Gilead Sciences over HIV prevention drug patents. The activists'…

Theo Sandoval · 2 min · July 13, 2026

Read story
02
Health

Tau therapies take center stage at London Alzheimer's conference, Biogen program in focus

A major Alzheimer's conference in London has placed tau therapies at the center of this week's scientific discussion, and data from Biogen's program is carrying the most anticipation. The tension is familiar to anyone…

Theo Sandoval · 2 min · July 13, 2026

Read story
03
Health

Tennessee's Ivermectin Loophole Is a Business Model, Not a Health Policy

Four years after Tennessee became the first state in the country to let adults purchase ivermectin from a pharmacy without first seeing a doctor, the antiparasitic drug has turned into a retail category unto itself…

Emmett Donovan · 2 min · June 20, 2026

Read story
04
Health

STAT Readers Push Back on Blue Zones Research and Open-Access Publishing Costs

STAT's reader debate section has surfaced pointed disagreements over two contested issues in life sciences: the scientific credibility of blue zones and the financial burden of open-access publishing fees. ## What First…

Emmett Donovan · 2 min · June 20, 2026

Read story
← All news